These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7736535)

  • 41. Immunological characterization of human decidual mononuclear cells: natural killer activity, response to interleukin-2 and distribution of interleukin-2 receptor subunits.
    Kurahayashi Y; Uehara S; Okamura K; Yajima A; Sugamura K
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):101-9. PubMed ID: 8172520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD8+/DR+/CD25--T-lymphocytes associated with marrow graft failure.
    Voltarelli JC; Przepiorka D; Shankar P; Kopecky K; Martin PJ; Torok-Storb B
    Bone Marrow Transplant; 1989 Nov; 4(6):647-52. PubMed ID: 2573398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-2 receptor monoclonal antibodies have no effect on anti-CD3 monoclonal antibody-mediated cytotoxicity in CD3+ leukemic large granular lymphocytes.
    Yoon HJ; Aprile JA; Loughran TP
    Cell Immunol; 1990 Dec; 131(2):404-8. PubMed ID: 2146989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
    Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
    Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection.
    Lyons A; Kelly JL; Rodrick ML; Mannick JA; Lederer JA
    Ann Surg; 1997 Oct; 226(4):450-8; discussion 458-60. PubMed ID: 9351713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro.
    Athreya BH; Pletcher J; Zulian F; Weiner DB; Williams WV
    Clin Immunol Immunopathol; 1993 Mar; 66(3):201-11. PubMed ID: 8094329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.
    Favrot M; Capdeville R; Combaret V; Zhou DC; Clapisson G; Banchereau J; Franks CR; Chouaib S; Blay JY; Philip T
    Eur Cytokine Netw; 1990; 1(3):141-7. PubMed ID: 2129798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of natural killer cells via the p75 interleukin 2 receptor.
    Phillips JH; Takeshita T; Sugamura K; Lanier LL
    J Exp Med; 1989 Jul; 170(1):291-6. PubMed ID: 2787381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Ohno T
    J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
    Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T
    Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation.
    Zola H; Weedon H; Thompson GR; Fung MC; Ingley E; Hapel AJ
    Immunology; 1991 Feb; 72(2):167-73. PubMed ID: 2016116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells.
    Raziuddin S; Assaf HM; Teklu B
    Eur J Immunol; 1989 Mar; 19(3):469-74. PubMed ID: 2523311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis.
    Trentin L; Migone N; Zambello R; di Celle PF; Aina F; Feruglio C; Bulian P; Masciarelli M; Agostini C; Cipriani A
    J Immunol; 1990 Oct; 145(7):2147-54. PubMed ID: 2144545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
    Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defective immunological functions associated with abnormal lymphokine-activated killer activity in patients with hepatocellular carcinoma.
    Shirai M; Watanabe S; Nishioka M
    J Gastroenterol Hepatol; 1990; 5(5):542-8. PubMed ID: 1966592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.